News
-
Dispensary Corner
Thursday | Apr 12 2018
12 Apr 18DOCTORS have issued a warning about eating super spicy food, after a US man ate a so-called 'Carolina Reaper' chilli pepper in a contest and ended up in hospital.
-
-
Flu vax advertising advice
Wednesday | Apr 11 2018THE Therapeutic Goods Administration has updated its guidance for advertising of vaccination services, reminding pharmacists there are strict controls around the release of information to the public.
-
MMJ Cannabis Access move
Wednesday | Apr 11 2018ASX-LISTED cannabis company MMJ PhytoTech has announced a $1 million investment for a 16.7% ownership stake in Biologics Research Institute, the owner of Cannabis Access, an online portal for medicinal cannabis access in Australia.
-
Leave certificates
Wednesday | Apr 11 2018THE Pharmacy Guild is reminding patients that with the pending flu season, their community pharmacy is the go-to place for vaccinations and absence from work certificates, especially where they are unable to get to their doctor easily.
-
PSA appoints Belinda Wood as GM
Wednesday | Apr 11 2018FORMER ceo of the Generic and Biosimilar Medicines Association (GBMA) Belinda Wood (pictured) has taken up the role of General Manager, Policy and Advocacy for the Pharmaceutical Society of Australia (PSA).
-
TGA Latuda approval
Wednesday | Apr 11 2018THE Therapeutic Goods Administration (TGA) has announced its approval of Latuda (lurasidone HCl) for the treatment of schizophrenia in adolescents (aged 13-17 years) as "an important therapy" for young patients with this debilitating mental illness.
-
Quit smoking course
Wednesday | Apr 11 2018THE Woolcock Institute of Medical Research has announced it will be hosting a 'Nicotine Addiction and Smoking Cessation Training' course with smoking cessation specialist and founding editor-in-chief of The Journal of Smoking Cessation, Associate Professor Renee Bittoun.
-
Immunotherapy hope
Wednesday | Apr 11 2018UNIVERSITY of Queensland (UQ)researchers have announced the development of a vaccine delivery technology called NanoEmulsion that enables treatment to be tailored precisely for different types of cancer.
-
Arrow nails it
Wednesday | Apr 11 2018ARROW Pharmaceuticals has announced that it is now Australia's exclusive distributor for Emtrix Nail, a topical treatment that promotes healing of discoloured and deformed nails caused by fungal infection or psoriasis.
